TGFbeta/BMP inhibits the bone marrow transformation capability of Hoxa9 by repressing its DNA-binding ability.
about
GSK-3 promotes conditional association of CREB and its coactivators with MEIS1 to facilitate HOX-mediated transcription and oncogenesisNon-transcriptional interactions of Hox proteins: inventory, facts, and future directionsStructural basis for homeodomain recognition by the cell-cycle regulator GemininHox specificity unique roles for cofactors and collaborators.miR-590-5p, miR-219-5p, miR-15b and miR-628-5p are commonly regulated by IL-3, GM-CSF and G-CSF in acute myeloid leukemia.HOXA9 participates in the transcriptional activation of E-selectin in endothelial cells.Cross-regulatory protein-protein interactions between Hox and Pax transcription factors.The role of Smad signaling in hematopoiesis and translational hematology.Future perspectives: therapeutic targeting of notch signalling may become a strategy in patients receiving stem cell transplantation for hematologic malignancies.Targeting self-renewal pathways in myeloid malignancies.Distinct DNA binding and transcriptional repression characteristics related to different ARX mutations.Directed neural differentiation of mouse embryonic stem cells is a sensitive system for the identification of novel Hox gene effectors.Two models of Smad4 and Hoxa9 complex are proposed: structural and interactional perspective.Recent advances in understanding hematopoiesis in Fanconi Anemia.
P2860
Q24319759-3A04C957-8FC0-4ACB-9811-249292425E15Q26991938-F92FE3B3-2C3E-4A08-9A94-0DC8EDDC2FECQ27679238-C735FE22-ACA2-4EDC-B2F5-83A4C2ACF58BQ33607453-3DDAEC0B-34F8-48F3-B2EE-30C9DB3EACC7Q35690892-4925EAA6-7C66-4CD4-B768-309E49C06430Q35857094-496A5ECE-4708-4CB8-9C80-4025B1D82930Q36869905-2855C766-2765-4E43-A6BB-CBD74FA63F1BQ37874928-01B278C9-F2FA-4D2B-8C01-EDFCD5FA71F2Q38803570-D57CBBE1-49F2-46CF-80BF-6326B842BFC8Q41104001-72FFC63D-20B3-457D-B77F-5C88B3FB9B55Q41120875-F757F47D-AE26-4FE2-9E3D-9F5A6C87AC7EQ42739791-A0A77A42-9A93-4BB9-9C92-85C074F3144EQ45981141-2A714579-09A2-45F4-940A-DD9E98953BEEQ48109237-7BB11899-9776-4093-829B-01993D366F02
P2860
TGFbeta/BMP inhibits the bone marrow transformation capability of Hoxa9 by repressing its DNA-binding ability.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
TGFbeta/BMP inhibits the bone ...... ssing its DNA-binding ability.
@ast
TGFbeta/BMP inhibits the bone ...... ssing its DNA-binding ability.
@en
TGFbeta/BMP inhibits the bone ...... ssing its DNA-binding ability.
@nl
type
label
TGFbeta/BMP inhibits the bone ...... ssing its DNA-binding ability.
@ast
TGFbeta/BMP inhibits the bone ...... ssing its DNA-binding ability.
@en
TGFbeta/BMP inhibits the bone ...... ssing its DNA-binding ability.
@nl
prefLabel
TGFbeta/BMP inhibits the bone ...... ssing its DNA-binding ability.
@ast
TGFbeta/BMP inhibits the bone ...... ssing its DNA-binding ability.
@en
TGFbeta/BMP inhibits the bone ...... ssing its DNA-binding ability.
@nl
P2093
P2860
P356
P1433
P1476
TGFbeta/BMP inhibits the bone ...... ssing its DNA-binding ability.
@en
P2093
Christopher A Klug
Claudiu V Cotta
Hyung-Gyoong Kim
P2860
P304
P356
10.1038/SJ.EMBOJ.7601037
P407
P577
2006-03-09T00:00:00Z